Cursiefen C, Colin J, Dana R, Diaz-Llopis M, Faraj LA, Garcia-Delpech S, Geerling G, Price FW, Remeijer L, Rouse BT, Seitz B, Udaondo P, Meller D, Dua H (2012)
Publication Type: Journal article
Publication year: 2012
Book Volume: 96
Pages Range: 3-9
Journal Issue: 1
The cornea is the clear window at the front of the eye and is the eye's main refractive medium. Its transparency is essential for vision. Corneal neovascularisation is a common clinical problem with serious consequences for vision; it can compromise corneal transparency and plays a major role in corneal graft rejection by breaching corneal immune privilege. In this review, we formulate a consensus on the unmet medical needs in the management of corneal neovascularisation and outline a framework for the clinical research that is needed to identify suitable agents to meet these needs.
APA:
Cursiefen, C., Colin, J., Dana, R., Diaz-Llopis, M., Faraj, L.A., Garcia-Delpech, S.,... Dua, H. (2012). Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable. British Journal of Ophthalmology, 96(1), 3-9. https://dx.doi.org/10.1136/bjo.2011.204701
MLA:
Cursiefen, Claus, et al. "Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable." British Journal of Ophthalmology 96.1 (2012): 3-9.
BibTeX: Download